# Invitation Homes Inc.: financial statements, quarterly

INVH · NYSE · CIK 1687229 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/invh.md) · [Financials](/companies/invh/financials.md) · [Filings](/companies/invh/filings.md) · [Insiders](/companies/invh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/invh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [624 d](/filings/0001687229-26-000016.md) | [646](/filings/0001687229-25-000019.md) | [653](/filings/0001687229-25-000036.md) | [660](/filings/0001687229-25-000051.md) | [659 d](/filings/0001687229-26-000016.md) | [0.0](/filings/0001687229-26-000032.md) | [0.0](/filings/0001687229-26-000045.md) | [0.0](/filings/0001687229-26-000056.md) | [2,729 d](/filings/0001687229-26-000016.md) | [43.7](/filings/0001687229-26-000032.md) | [49.5](/filings/0001687229-26-000045.md) | [35.8](/filings/0001687229-26-000056.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [90.0 d](/filings/0001687229-24-000013.md) | [89.8](/filings/0001687229-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2 d](/filings/0001687229-24-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [130 d](/filings/0001687229-26-000016.md) | [142](/filings/0001687229-25-000019.md) | [73.2](/filings/0001687229-25-000036.md) | [95.3](/filings/0001687229-25-000051.md) | [143 d](/filings/0001687229-26-000016.md) | [166](/filings/0001687229-26-000032.md) | [141](/filings/0001687229-26-000045.md) | [137](/filings/0001687229-26-000056.md) | [145 d](/filings/0001687229-26-000016.md) | [161](/filings/0001687229-26-000032.md) | [219](/filings/0001687229-26-000045.md) | [158](/filings/0001687229-26-000056.md) |
| Diluted EPS | $ per share | not reported | [0.23](/filings/0001687229-25-000019.md) | [0.12](/filings/0001687229-25-000036.md) | [0.15](/filings/0001687229-25-000051.md) | not reported | [0.27](/filings/0001687229-26-000032.md) | [0.23](/filings/0001687229-26-000045.md) | [0.22](/filings/0001687229-26-000056.md) | not reported | [0.26](/filings/0001687229-26-000032.md) | [0.37](/filings/0001687229-26-000045.md) | [0.27](/filings/0001687229-26-000056.md) |
| Basic EPS | $ per share | not reported | [0.23](/filings/0001687229-25-000019.md) | [0.12](/filings/0001687229-25-000036.md) | [0.16](/filings/0001687229-25-000051.md) | not reported | [0.27](/filings/0001687229-26-000032.md) | [0.23](/filings/0001687229-26-000045.md) | [0.22](/filings/0001687229-26-000056.md) | not reported | [0.26](/filings/0001687229-26-000032.md) | [0.37](/filings/0001687229-26-000045.md) | [0.27](/filings/0001687229-26-000056.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001687229-25-000008.md) | [0.7](/filings/0001687229-24-000028.md) | [0.7](/filings/0001687229-24-000046.md) | [1.0](/filings/0001687229-24-000074.md) | [0.2](/filings/0001687229-26-000016.md) | [0.1](/filings/0001687229-25-000019.md) | [0.1](/filings/0001687229-25-000036.md) | [0.2](/filings/0001687229-25-000051.md) | [0.1](/filings/0001687229-26-000056.md) | [0.1](/filings/0001687229-26-000032.md) | [0.1](/filings/0001687229-26-000045.md) | [0.1](/filings/0001687229-26-000056.md) |
| Total assets | $bn | [19.2](/filings/0001687229-25-000008.md) | [19.2](/filings/0001687229-24-000028.md) | [19.2](/filings/0001687229-24-000046.md) | [19.6](/filings/0001687229-24-000074.md) | [18.7](/filings/0001687229-26-000016.md) | [18.6](/filings/0001687229-25-000019.md) | [18.7](/filings/0001687229-25-000036.md) | [18.8](/filings/0001687229-25-000051.md) | [18.7](/filings/0001687229-26-000056.md) | [18.7](/filings/0001687229-26-000032.md) | [18.4](/filings/0001687229-26-000045.md) | [18.5](/filings/0001687229-26-000056.md) |
| Total liabilities | $bn | [9.0](/filings/0001687229-25-000008.md) | [9.0](/filings/0001687229-24-000028.md) | [9.2](/filings/0001687229-24-000046.md) | [9.7](/filings/0001687229-24-000074.md) | [8.9](/filings/0001687229-26-000016.md) | [8.8](/filings/0001687229-25-000019.md) | [9.0](/filings/0001687229-25-000036.md) | [9.1](/filings/0001687229-25-000051.md) | [9.1](/filings/0001687229-26-000056.md) | [9.6](/filings/0001687229-26-000032.md) | [9.4](/filings/0001687229-26-000045.md) | [9.7](/filings/0001687229-26-000056.md) |
| Long-term debt | $bn | [8.5](/filings/0001687229-24-000013.md) | [8.5](/filings/0001687229-24-000028.md) | [8.5](/filings/0001687229-24-000046.md) | [9.0](/filings/0001687229-24-000074.md) | [8.2](/filings/0001687229-25-000008.md) | [8.1](/filings/0001687229-25-000019.md) | [8.2](/filings/0001687229-25-000036.md) | [8.2](/filings/0001687229-25-000051.md) | [8.4](/filings/0001687229-26-000016.md) | [8.8](/filings/0001687229-26-000032.md) | [8.5](/filings/0001687229-26-000045.md) | [8.7](/filings/0001687229-26-000056.md) |
| Shareholders' equity | $bn | [10.2](/filings/0001687229-25-000008.md) | [10.1](/filings/0001687229-24-000028.md) | [10.0](/filings/0001687229-24-000046.md) | [9.9](/filings/0001687229-24-000074.md) | [9.8](/filings/0001687229-26-000016.md) | [9.7](/filings/0001687229-25-000019.md) | [9.7](/filings/0001687229-25-000036.md) | [9.6](/filings/0001687229-25-000051.md) | [9.5](/filings/0001687229-26-000056.md) | [9.1](/filings/0001687229-26-000032.md) | [9.1](/filings/0001687229-26-000045.md) | [8.8](/filings/0001687229-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [87.5 d](/filings/0001687229-26-000016.md) | [266](/filings/0001687229-25-000019.md) | [370 d](/filings/0001687229-25-000036.md) | [314 d](/filings/0001687229-25-000051.md) | [133 d](/filings/0001687229-26-000016.md) | [301](/filings/0001687229-26-000032.md) | [382 d](/filings/0001687229-26-000045.md) | [395 d](/filings/0001687229-26-000056.md) | [129 d](/filings/0001687229-26-000016.md) | [293](/filings/0001687229-26-000032.md) | [384 d](/filings/0001687229-26-000045.md) | [384 d](/filings/0001687229-26-000056.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [160](/filings/0001687229-25-000008.md) | [172](/filings/0001687229-26-000016.md) | [172](/filings/0001687229-26-000016.md) | [172](/filings/0001687229-26-000016.md) | [171](/filings/0001687229-26-000016.md) | [178](/filings/0001687229-26-000056.md) | [178](/filings/0001687229-26-000056.md) | [178](/filings/0001687229-26-000056.md) | [178](/filings/0001687229-26-000056.md) | [184](/filings/0001687229-26-000056.md) | [179](/filings/0001687229-26-000056.md) | [178](/filings/0001687229-26-000056.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001687229-26-000032.md) | [0.0 d](/filings/0001687229-26-000045.md) | [0.0 d](/filings/0001687229-26-000056.md) | [53.2 d](/filings/0001687229-26-000016.md) | [447](/filings/0001687229-26-000032.md) | [100 d](/filings/0001687229-26-000045.md) | [250 d](/filings/0001687229-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [613](/filings/0001687229-24-000028.md) | [613](/filings/0001687229-24-000046.md) | [614](/filings/0001687229-24-000074.md) | [614](/filings/0001687229-25-000019.md) | [614](/filings/0001687229-25-000036.md) | [614](/filings/0001687229-25-000051.md) | [613](/filings/0001687229-26-000032.md) | [613](/filings/0001687229-26-000045.md) | [613](/filings/0001687229-26-000056.md) | [606](/filings/0001687229-26-000032.md) | [592](/filings/0001687229-26-000045.md) | [589](/filings/0001687229-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 576,154,556 at 2026-10-28, from the cover of the [10-Q filed 2026-10-29](/filings/0001687229-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:42 ET. No prices; not investment advice.